Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Olympus Corp. | 1 | 0 | 0 | 0 | €15.13 | - | - |
| Ocular Therapeutix Inc. | 8 | 5 | 1 | 0 | €5.85 | €12.21 | 108.829% |
| Novo Nordisk A/S ADR | 16 | 1 | 0 | 0 | €122.50 | €135.22 | 10.383% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.79 | - | - |
| Novavax Inc. | 5 | 3 | 3 | 2 | €13.30 | €9.80 | -26.367% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €94.60 | - | - |
| Newron Pharmaceut. | 1 | 0 | 1 | 0 | €10.22 | - | - |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €129.60 | €140.60 | 8.490% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.66 | €3.70 | 122.892% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.95 | - | - |
| Myriad Genetics | 6 | 2 | 1 | 0 | €23.00 | €24.18 | 5.134% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €26.80 | - | - |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €68.30 | €65.00 | -4.832% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €314.30 | €366.73 | 16.681% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.00 | €86.90 | 17.428% |
| Merck KGaA | 3 | 1 | 0 | 0 | €165.30 | €146.00 | -11.676% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.00 | €124.93 | 3.247% |
| Medtronic plc | 9 | 1 | 0 | 0 | €77.98 | €93.46 | 19.845% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €366.20 | €421.61 | 15.130% |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.65 | €1.65 | 0.000% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €106.75 | €147.62 | 38.282% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.35 | €6.03 | 38.468% |
| MacroGenics Inc. | 12 | 0 | 4 | 0 | €3.98 | €12.99 | 226.104% |